Overall rank by patents
#2,851
Across all tracked assignees
USPTO PatentsView assignee record - 135 granted patents across 11 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
The verdict
Spine holds 135 US patents across 11 technology areas, rank #2,851 of 50,000 tracked assignees.
Spine WAVE, Inc. has been granted 135 US utility patents between 2015 and 2025, placing Spine WAVE, Inc. at rank #2,851 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.7 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Spine WAVE, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Spine sits between Omnitek Partners Llc (135 patents, rank #2,847) and Toagosei Co., Ltd. (135 patents, rank #2,855) - the closest US assignees by grant volume. The composite Innovation Score of 42.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 47 grants, compared with 88 in the 2015–2019 window, a -47% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Spine WAVE, Inc.'s 17.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Spine WAVE, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
OMNITEK PARTNERS LLC
135 patents
PetroChina Company Limited
135 patents
RH US, LLC
135 patents
SANECHIPS TECHNOLOGY CO., LTD.
135 patents
SUNTORY FLOWERS LIMITED
135 patents
Second Sight Medical Products, Inc.
135 patents
TAMURA CORPORATION
135 patents
TOAGOSEI CO., LTD.
135 patents
SPINE WAVE, INC.
135 patents
What this shows Spine holds 135 patents at rank #2,851, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,851 in granted patent volume.
Other assignees with the most granted patents in Spine's primary technology class.
Spine's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
43 Top 30% higher than 70% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 17 | 12.6% |
| 2016 | 20 | 14.8% |
| 2017 | 16 | 11.9% |
| 2018 | 18 | 13.3% |
| 2019 | 17 | 12.6% |
| 2020 | 8 | 5.9% |
| 2021 | 12 | 8.9% |
| 2022 | 7 | 5.2% |
| 2023 | 7 | 5.2% |
| 2024 | 5 | 3.7% |
| 2025 | 8 | 5.9% |
Top 11 of 11 technology areas
Overall rank by patents
#2,851
Across all tracked assignees
42.8 out of 100
How to use this portfolio
Spine's 135 grants land it in the top 30% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.